Development of Novel Multimodal Dextran-Based Theranostic Tracers: Targeting Fibroblast Activation Protein as Proof of Concept

Informations projet

POLYTROP

N° de convention de subvention: 101130787

DOI

10.3030/101130787

Projet clôturé

Date de signature de la CE 11 Mai 2023

Date de début 1 Juin 2023

Date de fin 31 Mai 2025

Financé au titre de

• Widening participation and spreading excellence

Coût total

Aucune donnée

Contribution de l’UE

€ 169 326,72

Coordonné par

"NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""
Greece

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected, processed or generated by the action. It is adocument describing what data will be collected, processed or generated andfollowing what methodology and standards, whether and how this data will beshared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens.

Publications

Peer reviewed articles (4)

Mixed ligand Re and 99mTc tricarbonyl complexes bearing two important pharmacophores: 2-(4′-aminophenyl)benzothiazole and curcumin

Auteurs: Alexandros Stouraitis, Marina Sagnou, Barbara Mavroidi, Christos Kiritsis, Antonio Shegani, Catherine Raptopoulou, Vassilis Psycharis, Constantinos Methenitis, Ioannis Pirmettis, Minas Papadopoulos, Maria Pelecanou
Publié dans: Inorganica Chimica Acta, Numéro 571, 2024, ISSN 0020-1693
Éditeur: Elsevier BV
DOI: 10.1016/J.ICA.2024.122172

Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting

Auteurs: Sotiria Triantopoulou, Ioanna Roupa, Antonio Shegani, Nektarios N. Pirmettis, Georgia I. Terzoudi, Aristeidis Chiotellis, Maria Tolia, John Damilakis, Ioannis Pirmettis, Maria Paravatou-Petsota
Publié dans: Pharmaceutics, Numéro 16, 2024, ISSN 1999-4923
Éditeur: MDPI AG
DOI: 10.3390/PHARMACEUTICS16091213

Pharmaceutics

Auteurs: A. Papasavva, N. N. Pirmettis, A. Shegani, E. Papadopoulou, C. Kiritsis, M. Georgoutsou-Spyridonos, D. C. Mastellos, A. Chiotellis, P. Kyprianidou, M. Pelecanou, M. Papadopoulos, I. Pirmettis
Publié dans: Pharmaceutics, 2024, ISSN 1999-4923
Éditeur: MDPI
DOI: 10.3390/PHARMACEUTICS16091210

Synthesis and characterization of rhenium and Technetium-99 m tricarbonyl and dicarbonyl complexes with quinaldic acid and Arsenic/Phosphorus derivatives

Auteurs: Charalampos Triantis, Antonio Shegani, Aristeidis Chiotellis, Catherine Raptopoulou, Vassilis Psycharis, Maria Pelecanou, Ioannis Pirmettis, Minas Papadopoulos
Publié dans: Polyhedron, Numéro 264, 2024, ISSN 0277-5387
Éditeur: Elsevier BV
DOI: 10.1016/J.POLY.2024.117236